We are live on ! Find out more
PG

Prostatis Group Portfolio holdings

AUM $391M
1-Year Est. Return 20.37%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+20.37%
3 Year Est. Return
+56.13%
5 Year Est. Return
+74.88%
10 Year Est. Return
AUM
$239M
AUM Growth
+$34.6M
Cap. Flow
+$17.3M
Cap. Flow %
7.23%
Top 10 Hldgs %
39.54%
Holding
142
New
30
Increased
47
Reduced
48
Closed
12
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VDE icon
26
Vanguard Energy ETF
VDE
$9.76B
$2.73M 1.14%
23,297
+20,814
+838% +$2.5M
AAPL icon
27
Apple
AAPL
$4.9T
$2.7M 1.13%
14,006
+3,325
+31% +$614K
CALF icon
28
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.55B
$2.58M 1.08%
53,814
+7,320
+16% +$314K
JEPI icon
29
JPMorgan Equity Premium Income ETF
JEPI
$45B
$2.52M 1.05%
45,758
+6,783
+17% +$366K
HYLS icon
30
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.64B
$2.38M 0.99%
57,208
+6,997
+14% +$279K
IVV icon
31
iShares Core S&P 500 ETF
IVV
$881B
$2.32M 0.97%
4,851
+2,031
+72% +$909K
MSFT icon
32
Microsoft
MSFT
$2.93T
$2.25M 0.94%
5,986
+235
+4% +$83.6K
IDV icon
33
iShares International Select Dividend ETF
IDV
$8.28B
$2.23M 0.93%
79,721
+11,802
+17% +$308K
BLV icon
34
Vanguard Long-Term Bond ETF
BLV
$5.85B
$2.09M 0.87%
28,007
-2,114
-7% -$145K
VTV icon
35
Vanguard Value ETF
VTV
$186B
$2.02M 0.84%
13,486
-998
-7% -$140K
XRT icon
36
State Street SPDR S&P Retail ETF
XRT
$452M
$1.96M 0.82%
+27,051
New +$1.72M
HYG icon
37
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.9B
$1.77M 0.74%
22,928
+754
+3% +$56.2K
IJR icon
38
iShares Core S&P Small-Cap ETF
IJR
$110B
$1.77M 0.74%
16,367
+12,943
+378% +$1.25M
HD icon
39
Home Depot
HD
$338B
$1.66M 0.69%
4,776
+154
+3% +$47.7K
BND icon
40
Vanguard Total Bond Market
BND
$159B
$1.56M 0.65%
21,202
-1,346
-6% -$95K
FPE icon
41
First Trust Preferred Securities and Income ETF
FPE
$6.36B
$1.51M 0.63%
89,825
+13,884
+18% +$224K
XHB icon
42
State Street SPDR S&P Homebuilders ETF
XHB
$2.08B
$1.48M 0.62%
+15,498
New +$1.26M
TMO icon
43
Thermo Fisher Scientific
TMO
$198B
$1.44M 0.6%
2,722
-107
-4% -$51.8K
CVX icon
44
Chevron
CVX
$373B
$1.43M 0.6%
9,601
+26
+0.3% +$3.93K
VNQ icon
45
Vanguard Real Estate ETF
VNQ
$39.6B
$1.41M 0.59%
+15,954
New +$1.26M
IGLD icon
46
FT Vest Gold Strategy Target Income ETF
IGLD
$500M
$1.37M 0.57%
71,538
+12,501
+21% +$233K
NEE icon
47
NextEra Energy
NEE
$185B
$1.37M 0.57%
22,547
+18,119
+409% +$1.03M
XOM icon
48
ExxonMobil
XOM
$611B
$1.36M 0.57%
13,622
-1,049
-7% -$110K
IJH icon
49
iShares Core S&P Mid-Cap ETF
IJH
$122B
$1.34M 0.56%
+24,140
New +$1.22M
VV icon
50
Vanguard Large-Cap ETF
VV
$52.2B
$1.33M 0.55%
6,080
-789
-11% -$161K

Similar funds

Prostatis Group's Q4 2023 Portfolio in Review

As of Q4 2023, Prostatis Group held 142 positions worth $239M, up 17% from $205M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prostatis Group deployed $17.3M of net new capital in Q4 2023, opening 30 new positions and adding to 47 existing holdings. Its largest new stake was First Trust Energy AlphaDEX Fund: 378,334 shares worth $6.31M.

By sector, the portfolio is most concentrated in Technology at 3.6% of assets, up from 3.2% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, an estimated $17.4M trimmed.

  • Prostatis Group's largest Q4 2023 buy was First Trust Energy AlphaDEX Fund: 378,334 shares worth $6.31M.
  • Prostatis Group added most to Invesco QQQ Trust in Q4 2023, an estimated $17.4M increase.
  • Prostatis Group's biggest Q4 2023 reduction was State Street SPDR Bloomberg 1-3 Month T-Bill ETF, cutting an estimated $17.4M.
  • Prostatis Group fully exited iShares 0-1 Year Treasury Bond ETF in Q4 2023, selling an estimated $9.43M.
  • Prostatis Group's ten largest holdings make up 40% of its $239M portfolio in Q4 2023.
  • Prostatis Group opened 30 new positions and closed 12 in Q4 2023.
  • Prostatis Group's portfolio value rose 17% quarter-over-quarter to $239M.

Based on Prostatis Group's 13F filing for Q4 2023, filed 21 Mar 2025.